Elsevier

Radiotherapy and Oncology

Volume 20, Issue 2, February 1991, Pages 99-110
Radiotherapy and Oncology

Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas

https://doi.org/10.1016/0167-8140(91)90143-5Get rights and content

Abstract

Between January 1982 and June 1986, 60 consecutive patients with high-grade astrocytomas [39 glioblastoma multiforme (GBM), 21 anaplastic astrocytoma (AA)] were treated with radiation therapy after biopsy (13 patients) or resection (47 patients). Fifty-three patients were treated with limited-volume irradiation, and seven patients received whole-brain irradiation. The mean tumor dose was 65.4 Gy. In 35 patients, chemotherapy was given as part of their initial treatment. The 1- and 2-year survivals for GBM patients were 40 and 14 %, respectively. Survival figures for AA patients were 76 and 52 % at 1 and 2 years, respectively. The progression-free rate at 1 year was 13% in GBM and 29% in AA patients. Thirty-four of 48 patients who received limited-volume irradiation had evidence of progression on postirradiation CT scans. Six patients (3 GBM, 3 AA) had evidence of a new intracranial metastatic site on CT scan. In three patients the mestastasis was within the previously irradiated volume, and in the other three patients, it was outside this volume. All six had evidence of progression of their primary tumor at the original location on CT scan prior to the discovery of the mestastatic site. Twenty-one patients (15 GBM, 6 AA) had at least one postirradiation reoperation for a recurrent mass. Nineteen patients had recurrent tumors in the primary site, and two patients had necrosis but no tumor. Patients who received limited-volume irradiation for high-grade astrocytomas achieved the same survival results as patients treated previously with whole brain irradiation. New intracranial metastases did not influence the outcome, since these were always antedated by tumor progression at the primary site.

References (16)

There are more references available in the full text version of this article.

Cited by (128)

  • Glioblastoma: Radiation treatment margins, how small is large enough?

    2016, Practical Radiation Oncology
    Citation Excerpt :

    It was believed that patients who achieve long-term survival could benefit from a focal approach to treatment that spares them delayed radiation toxicity.14,16 Although no other randomized trials have been reported strictly comparing WBRT with partial brain radiation therapy (RT), several retrospective studies17–19 have demonstrated no difference in overall survival (OS) between WBRT and focal irradiation techniques. These same studies have also reported that recurrence patterns were consistent with previous autopsy studies in patients who received WBRT as well as those treated with focal RT.

  • Aspects of hypofractionation in modern radiation oncology

    2023, Ukrainian Journal of Radiology and Oncology
View all citing articles on Scopus
View full text